1[1]Jau-Ling Huang,Jyh-Hsiung Huang,Ron-Hwa Shyu,et al.High-level expression of recombinant dengue viral NS-1 protein and its potential use as a diagnostic antigen.J Med Viro,2001,65:553-560.
2[2]Sudiro TM,Ishiko H,Green S,et al.Rapid diagnosis of dengue viremia by reverse transcriptase-polymerase chain reaction using 3'-noncoding region universal primers.Am J Trop Med Hyg,1997,56(4):424-428.
3[3]Lanciotti RS,Calisher CH,Gubler DJ,et al.Rapid detection and typing of dengue viruses from clinical samoles by using reverse transcriptase-polymerase chain reaction.Clin Microbiol,1992,30(3):545-551.
5[5]Shuenn-Juel WU,Eun milee,Ravithat putvatana ,et al.Detection of dengue viral RNA using a nucleic acid sequence-based amplification assay.J Clini Micro,2001,39(8):2794-2799.
6[6]Robert R,Porter KR,Kochel TJ,et al.Protective efficacy of a dengue 2 DNA vaccine in mice and the effect of CpG immuno-stimulatory motifs on antibody responses.Arch Virol,1998,143(5):997-1003.
7[7]Raviprakash K,Kochel TJ,Ewing D,et al.Immunogenicity of dengue virus type 1 DNA vaccines expressing turncated and full length envelope protein.Vaccine,2000,18(22):2426-2435.
8[8]Marlkoff L,Pang X,Houng HS.Derivation and characterization of a dengue type 1 host range-restricted mutant virus that is attenuated and highly immunogenic in monkeys.J Virol,2002,Apr:76(7):3318-28.
9[9]Brandt WE.From the World Health Organization:Development of dengue and Japanese encephalitis vaccines.J Infect Dis,1990,162(3):577-582.
10[10]Velzing J,Groen J,Drouet MT,et al.Infection of protective immunity against Dengue virus type2:comparison of candidate live attenuated and recombinant vaccines.Vaccine,1999,17(11-12):1312-1316.
